Involvement of hormones and their receptors in the progression of low-and high-grade glioma - Archive ouverte HAL Accéder directement au contenu
Communication Dans Un Congrès Année : 2022

Involvement of hormones and their receptors in the progression of low-and high-grade glioma

Résumé

Introduction : Gliomas are the most common primary brain tumors in adults. The WHO classifies these tumors according to their degree of malignancy (histologicalgrade 1 to 4) and molecular subtype (IDH1 gene mutation, 1p19q codeletion):astrocytoma, oligodendroglioma and glioblastoma (IDHwt grade 4). Conventional treatment of glioblastoma consists in a concomitant radio-chemotherapy (temozolomide) and in some cases a chirurgical resection. Despite, the 5-yearsurvival rate is less than 5 %. Few risk factors are clearly defined, but womenare 1.5-fold less affected than men. Based on these observations, wehypothesized that hormonal and particularly estrogenic signaling have neuroprotective properties and addressed the key role of the g-protein coupled estrogen receptor GPER1. Material and Methods : The association between patient survival and the expressions of GPER1 or its related genes was investigated through the mining of TCGA-LGG/GBM databasesand a workflow of statistical and bioinformatics analyses. The impact of GPERactivity on tumor growth was also explored in ex vivo cultured low- and high-grade patient samples and glioblastoma primary or established cell lines exposedto GPER1 agonist (G-1) and/or temozolomide and/or radiotherapy. Results and Discussions : For the first time, we highlighted the association between a high GPER1 expression and patient survival and identified gender and tumor subtype specific related-gene signatures of good prognosis. Ex vivo, G-1 induced a significant decrease in glioblastoma cell proliferation. We observed a cell cycle arrest inG2/M phase caused by a disruption of the microtubular network. Finally, G-1potentiated the efficacy of standard treatment, even in chemotherapy less-sensitive cells, and could lead to cell apoptosis. Conclusion : Taken together, our results supported the hormone-sensitivity of low- and high grade glioma and suggested that G-1, in combination with standard therapy,might be a promising way to limit the progression and aggressiveness of GBM.We also highlighted the need for a gender-specific approach to both investigatethe mechanisms that underly glioma progression and search for more efficient and tailored therapies of this still incurable disease.

Domaines

Cancer
Fichier non déposé

Dates et versions

hal-03735741 , version 1 (22-07-2022)

Identifiants

  • HAL Id : hal-03735741 , version 1

Citer

Alex Hirtz, Yann Bailly, Nolwenn Lebourdais, Fabien Rech, Hélène Dubois-Pot-Schneider, et al.. Involvement of hormones and their receptors in the progression of low-and high-grade glioma. 28th Congress of the European Association for Cancer Research, EACR 2022, Jun 2022, Seville, Spain. ⟨hal-03735741⟩
28 Consultations
0 Téléchargements

Partager

Gmail Facebook X LinkedIn More